What started out in a basement at the technical University Eindhoven has now developed into a thought leader in nanofiber-based solutions for the MedTech and Pharma industry. VIVOLTA’s unique nanofiber-based technology is now being used by players spread-out over six continents. This is where nearly fifteen years of hard work have brought us.

VIVOLTA has evolved from a research equipment manufacturer into a full-service medical solution provider. During this transformation, VIVOLTA’s engineering and application team developed a unique large-scale production platform for nanofiber-based medical solutions, the MediSpin® platform. In this platform the knowledge, network, and supply chain of the ‘Brainport’ region in the Netherlands is leveraged, the cradle of High-Tech companies such as Philips and ASML. VIVOLTA also contributed to the first ASTM standard for fiber-based medical scaffolds (F3519-21), published in May 2021, underlining VIVOLTA’s unique and pioneering position in the field.

With these accomplished achievements, VIVOLTA is now truly ready to serve its focus areas of Women’s Health, Tissue Engineering, and Drug Delivery to improve patients’ lives with its nanofiber-based solutions.